Effectiveness of the RB51 vaccine in controlling brucellosis in adult beef cows
Open Access
- 15 November 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 11, 1440599
Abstract
Introduction: The aim of this study was to compare the effectiveness of brucellosis control and reproductive performance using one or two doses of RB51 strain vaccine.Methods: This experiment was conducted at two commercial beef farms (A, n = 477; and B, n = 673), which were selected due to their records of endemic brucellosis and a prevalence of 6 to 8% of seropositive cows. An initial serology screening (Day 0) was carried out in all cows using the Rose Bengal test (RB), and presumptive positive results were re-evaluated using a slow agglutination test with 2-mercaptoethanol (2-ME). Seropositive cows (64, 5.6%) were culled. Non-reactive cows were then randomly assigned into three experimental groups: G1, a single vaccination with RB51; G2, two doses of RB51 given 6 months apart; and G3 (control group), no vaccination. Serological tests were carried out on Days 90, 180, 270, and 360. In each evaluation, seropositive cows were removed. The variables related to occurrence of new infections and abortion, as well as those related to subsequent reproductive performance, were analyzed using the SAS software.Results and discussion: Seropositive cows were still detected in both vaccinated and control groups at 90 days. However, no new infections were detected in G1 at 180 days or in G1 and G2 at 270 and 360 days, whereas new seropositive cows were diagnosed in all exams in G3 (control). Therefore, the cumulative number of new infections was lower in vaccinated than in control cows (0.2% and 0.0%, vs. 3.2% for groups G1, G2, and G3 respectively; p = 0.0002). In farm A the number of days open was greater in the control than in vaccinated groups (p < 0.05), and in farm B the pregnancy rate was lower in the control than in the group vaccinated once (p < 0.05). In summary, vaccination with RB51 in beef cows reduces the occurrence of new cases of brucellosis and improves the reproductive performance. There is no indication that a second immunization, six months after the first, enhances protection or reproductive efficiency.Keywords
This publication has 18 references indexed in Scilit:
- Bovine Brucellosis in Argentina and Bordering Countries: UpdateTransboundary and Emerging Diseases, 2012
- Seroepidemiological study of livestock brucellosis in a pastoral regionEpidemiology and Infection, 2011
- Seroprevalence of brucellosis and its contribution to abortion in cattle, camel, and goat kept under pastoral management in Borana, EthiopiaTropical Animal Health and Production, 2010
- Mass vaccination as a complementary tool in the control of a severe outbreak of bovine brucellosis due to Brucella abortus in Extremadura, SpainPreventive Veterinary Medicine, 2010
- Diagnosis of Brucellosis in Livestock and WildlifeCroatian Medical Journal, 2010
- Eradication of bovine brucellosis in the Azores, Portugal—Outcome of a 5-year programme (2002–2007) based on test-and-slaughter and RB51 vaccinationPreventive Veterinary Medicine, 2009
- Bovine brucellosis control and eradication programme in Chile: vaccine use as a tool within the programme.2004
- The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United StatesVeterinary Microbiology, 2002
- Brucellosis vaccines: past, present and futureVeterinary Microbiology, 2002
- Economic evaluation of bovine brucellosis and tuberculosis eradication programmes in a mountain area of SpainPreventive Veterinary Medicine, 1997